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During infection with human cytomegalovirus (HCMV), overexpression of hcmv-miR-US33 can inhi-
bit the lytic viral replication and down-regulate US29mRNA. However, it remains unknown whether
inhibition of viral replication by miR-US33 is mediated by down-regulation of expression of US29 or
another host gene. Here, we identiﬁed the host gene Syntaxin3 (STX3) to be a direct target of
hcmv-miR-US33-5p using Hybrid-PCR and luciferase-reporter assays. It was further demonstrated
that the levels of STX3 protein were down-regulated in hcmv-miR-US33-5p-overexpressing cells.
Experiments with STX3-speciﬁc siRNA, or with an inhibitor of hcmv-miR-US33-5p conﬁrmed that
hcmv-miR-US33-5p-mediated inhibition of HCMV DNA synthesis and of viral replication are
speciﬁcally mediated by down-regulation of STX3 expression.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Human cytomegalovirus (HCMV) is a prevalent human patho-
gen that can cause signiﬁcant morbidity and mortality in newborns
and immunocompromised patients [1]. HCMV has a 230 kb gen-
ome and encodes at least 26 mature microRNAs (miRNA) from
16 precursors [2]. Post-transcriptional regulation of miRNAs on
their target mRNAs is thought to be achieved via the bindings
between nucleotides located at 2–7 at the 50 end of miRNAs
(named as seed region) and sequences at the 30 untranslated region
(30-UTR) of target mRNAs [3]. Since the ﬁrst virus expressed miR-
NAs were reported [4], many viral miRNAs have been discovered.
Emerging evidences suggest that miRNAs may be associated with
immune evasion, latency of herpes virus subfamily and regulation
of viral replication [5–7]. It has been reported that over-expression
of hcmv-miR-US33 can inhibit the lytic viral replication and down-
regulate US29 mRNA in the context of HCMV infection [8].
Whether inhibition of HCMV replication by hcmv-miR-US33 is
mediated by down-regulation of US29 expression or of other host
gene expressions remains elusive.In the present study, it was found that over expression of hcmv-
miR-US33-5p, which is one miRNA derived from the precursor of
hcmv-miR-US33, obviously reduce HCMV DNA synthesis.
Syntaxin3 (STX3), a soluble N-ethylmaleimide sensitive factor
attachment protein receptor protein, which participates in the cel-
lular membrane fusion [9], was identiﬁed as a direct target of
hcmv-miR-US33-5p. Inhibition of STX3 by hcmv-miR-US33-5p or
its speciﬁc small interference RNA can reduce the synthesis of
HCMV DNA.
2. Materials and methods
2.1. Cell culture and virus preparation
Human embryonic kidney cells (HEK 293) were maintained in
Dulbecco’s modiﬁed Eagle medium (DMEM) containing 10% fetal
bovine serum (FBS), 100 units/ml penicillin and streptomycin.
MRC-5 cells were maintained in minimal essential medium
(MEM) supplemented with 15% FBS, 100 units/ml penicillin and
streptomycin. A low passage HCMV isolate, Han, was isolated from
a urine sample of a 5-month-old infant hospitalized in Shengjing
Hospital of China Medical University. Han strain was passaged in
MRC-5 cells maintained in MEM supplemented with 2% FBS,
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chromosome of HCMV Han strain (HCMV Han BAC) carrying the
enhanced green ﬂuorescent protein coding sequence has been con-
structed by cooperation with professor Minhua Luo in Wuhan
Institute of Virology, Chinese Academy of Sciences and doctor
Hua Zhu in UMDNJ-New Jersey Medical School, USA (In express).
2.2. RNA isolation
Total RNAs was isolated from HCMV infected or uninfected
MRC-5 cells using Trizol reagent (Invitrogen), chloroform and
isopropanol according to the protocol. The extracted RNA was dis-
solved in 100 ll RNase free H2O and treated by TURBO DNA-free™
Kit (Ambion). The qualities and purities of the RNA preparations
were estimated by electrophoresis on 1% agarose gel and the quan-
tities were detected by ND-1000 spectrophotometer (Nanodrop
Technologies).
2.3. Quantitative real-time PCR
To evaluate hcmv-miR-US33-5p expression in infected cells,
MRC-5 cells growing in 60 mm plates were inoculated with HCMV
Han strain at a multiplicity of infection (MOI) of 3 infectious parti-
cles per cell. Total RNAs were extracted from uninfected cells and
infected cells at 24, 48, 72, 96 and 120 hours post infection (hpi).
Reverse transcription (RT) was performed using hcmv-miR-US33-
5p speciﬁc primer or primer of small nucleolus RNA (snRNA) U6
(Applied Biosystems) with TaqMan miRNA reverse transcription
kit (Applied Biosystems). Quantitative PCR was carried out with
Universal PCR Master Mix Kit (Applied Biosystems) and speciﬁc
TaqMan probes of hcmv-miR-US33-5p and snRNA U6 (Applied
Biosystems) following the manufacture’s protocol using Applied
Biosystems 7300 Fast Real-Time PCR System. The relative expres-
sion level of hcmv-miR-US33-5p was normalized to that of snRNA
U6 in corresponding samples by 2DDCT method [10].
2.4. Hybrid-PCR and sequencing
Reverse transcription was performed using 1 lg total RNAs
from Han infected MRC-5 cells and 30-Full RACE Core Set kit (TaKa-
Ra). Based on the principles described before [11], the compatible
hcmv-miR-US33-5p hybrid-primer was designed and synthesized
as follow: 50-CGCCCRCGGTCCGGGCRCRRT-30 (R = A or G). Hybrid-
PCR was carried out using nested primers (outer primer: 50-TAC-
CGTCGTTCCACTAGTGATTT-30 and inner primer: 50-CGCGGATCCT
CCACTAGTGATTTCACTATAGG-30), which are homologous to the
introduced sequence of the cDNA, and the hcmv-miR-US33-5P
hybrid-primer. The ﬁrst round ampliﬁcation of hybrid-PCR was
hot started at 72 C, followed by 30-cycle ampliﬁcation at an
annealing temperature of 37 C. 1 ll product of the ﬁrst round
ampliﬁcation was used as templates in the second round PCR, in
which the annealing temperature was increased to 55 C. All prod-
ucts were gel-puriﬁed and cloned into PCR2.1 vectors (Invitrogen).
Individual colony was randomly selected and the inserts of the
selected colonies were sequenced on an ABI 3730 automated
sequencer. mRNA speciﬁc sequences located between the corre-
sponding sequence of the hcmv-miR-33-5p hybrid-primer and
the polyA structure were intercepted and used to blast on line
(http://www.ncbi.nlm.nih.gov/blast).
2.5. Plasmid construction
The 30-untranslated region (30-UTR) of STX3 was ampliﬁed from
mRNA derived cDNA by STX3 speciﬁc primers of 50-GGACTAG
TCTGGCAGTCTCCTTGATT-30 (sense) and 50-CCCAAGCTTGGCCTT-
TAGTTATTTTGTCT-30 (antisense). After puriﬁcation and digestion,the fragment was cloned into the Spe I and Hind III sites of pMIR-
REPORT ﬁreﬂy luciferase (FFL) vector (Promega), named as pMIR-
STX3-UTR. A mutant vector, pMIR-STX3-MUT, containing three
point mutations of the putative binding site of hcmv-miR-US33-
5p was generated from the pMIR-STX3-UTR using pyrobest DNA
polymerase (TaKaRa) and a mutant primer of 50-aggctacttat
ggccggtcgcgctccagcactcagacaga-30 (Characters underlined present
mutant nucleotides) according to the protocol of Site-directed
Gene Mutagenesis Kit (Beyotime). Inserts in all the constructs were
sequenced on an ABI 3730 automated sequencer.
2.6. Dual-luciferase reporter assays
To assess binding ability of hcmv-miR-US33-5p to STX3 30-UTR,
HEK293 cells were cultured in 24-well plates. The cells were co-
transfected with 100 nM miRNA negative control (RiboBio), which
has the lowest homology with any known miRNAs, or hcmv-miR-
US33-5p mimics (RiboBio) together with 100 ng pRL-TK-Renilla-
luciferase plasmid (Promega), and respectively with 200 ng
pMIR-REPORT vector, pMIR-STX3-UTR or pMIR-STX3-MUT using
Lipofectamine 2000 (Invitrogen) in triplicate wells.
Luciferase activities were measured using Dual Luciferase
Reporter Assay System (Promega) at 48 hour post transfection
according to the manufacturer’s instructions. The transfection
efﬁciencies were normalized by the renilla luciferase activities in
corresponding wells.
2.7. Western blot
To analyze whether STX3 protein expression is affected by
hcmv-miR-US33-5p during HCMV infection, MRC-5 cells cultured
in 60 mm tissue culture plates were transfected respectively with
miRNA negative control, hcmv-miR-US33-5p mimics and inhibitor
for hcmv-miR-US33-5p (RiboBio). Six hours later, the cells were
inoculated with HCMV Han strain at MOI of 0.5 PFU per cell. At
48 hpi, the infected cells were collected and lysed using mamma-
lian protein extraction reagent (M-PER, Thermo). Proteins were
separated on 12% SDS–PAGE gels and transferred onto polyvinyli-
dene ﬂuoride (PVDF) membranes. The protein levels of STX3 and
glyceraldehydes-3-phosphate dehydrogenase (GAPDH) were
detected using speciﬁc antibodies of rabbit monoclonal anti-STX3
(Abcam) and mouse monoclonal anti-GAPDH (Santa Cruz), and
horseradish peroxidase (HRP)-conjugated secondary antibodies
(Zhong Shan), respectively. The blots were visualized via an elec-
trochemiluminescence (ECL) detection system and were exposed
using ChemiDocTM XRS+ (Bio RAD). Meanwhile, expressions of
hcmv-miR-US33-5p in the MRC-5 cells were detected by quantita-
tive real-time PCR as described above.
2.8. Viral DNA quantiﬁcation
MRC-5 cells were transfected respectively with miRNA negative
control, hcmv-miR-US33-5p mimics, inhibitor for hcmv-miR-
US33-5p and small interference RNA (siRNA) for STX3 (Ambion).
Six hours later, the cells were inoculated with HCMV Han strain
at MOI of 0.5 PFU per cell and harvested at 48 hpi using phosphate
buffered saline (PBS). DNA was extracted from the infected cells
using General Allgen Kit (Cwbio). The DNA copies of HCMV and a
cellular housekeeping gene b-Actin were quantiﬁed with a pair of
HCMV UL83 gene speciﬁc primers (sense: 50-GGGACACAACACCG-
TAAAGC-30 and antisense: 50-GTCAGCGTTCGTGTTTCCCA-30) [12]
and a pair of b-Actin speciﬁc primers (sense: 50-CGGAACCGCT-
CATTGCC-30 and antisense: 50-ACCCACACTGTGCCCATCTA-30),
respectively, using Power SYBR Green PCR Master Mix (Applied
Biosystems). The relative viral DNA level was normalized to that
of b-Actin in the corresponding sample by 2DDCT method.
Fig. 1. Expressions of hcmv-miR-US33-5p in HCMV Han strain infected MRC-5
cells. Expression of hcmv-miR-US33-5p was quantiﬁed by RT-qPCR using speciﬁc
probe for hcmv-miR-US33-5p at the indicated time points post infection and
normalized to the copies of snRNA U6 in the corresponding samples by 2DDCT
method. The assays were performed in triplicate wells.
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infected MRC-5 cells were detected by Western blot as described
above.
2.9. Growth curve analysis
MRC-5 cells grown in 6-well plates were transfected respec-
tively with miRNA negative control, hcmv-miR-US33-5p mimics,
inhibitor of hcmv-miR-US33-5p and siRNA of STX3. Six hours later,
the cells were inoculated with HCMV Han BAC virus. After 2 h
incubation, the cells were washed once, and maintained in MEM
supplemented with 2% FBS. At 24 hpi, 48 hpi and 72 hpi, the cells
were collected with 2 ml media, frozen and thawed three times.
Infectious particles in the recovered supernatants were titrated
by 50% tissue culture infective dose assay by counting the infected
cells with green ﬂuorescence at 11 days post inoculation.
2.10. Statistics
Data from three independent repetitions are recorded as
mean ± S.E. and used in statistical analyses (But those of the
growth curve analysis). Statistical signiﬁcance was determined
by Student’s t-test. P < 0.01 was considered to be statistical
signiﬁcant.Table 1
Putative targets of HCMV miR-US33-1-5p identiﬁed by hybrid-PCR.
mRNA names
Homo sapiens OTU domain containing 5, mRNA
Homo sapiens exostoses (multiple)-like 3, mRNA
Homo sapiens SPTBN1 mRNA for spectrin beta non-erythrocytic 1
Homo sapiens syntaxin 3 (STX3), mRNA
Homo sapiens adenylate kinase 3 (AK3), mRNA
Homo sapiens H1 histone family, member X (H1FX), mRNA
Homo sapiens TIMP metallopeptidase inhibitor 2 (TIMP2), mRNA
Homo sapiens polymerase (RNA) II polypeptide F, mRNA
Homo sapiens spectrin, alpha, non-erythrocytic 1 (alpha-fodrin), mRNA
Homo sapiens chaperonin containing TCP1, subunit 2 (beta) , mRNA
Human herpesvirus 5 isolate Han80 UL16 protein (UL16) and UL17 protein (UL17) m
Human herpesvirus 5 isolate Han145 UL144 protein (UL144) mRNA, partial cds; and
complete cds3. Results
3.1. hcmv-miR-US33-5p is expressed in HCMV infected cells
Expression kinetics of hcmv-miR-US33-5p during HCMV infec-
tion was determined in infected MRC-5 cells at different time
points post infection. As shown in Fig. 1, hcmv-miR-US33-5p
increased at 24 hpi and reached the highest level at 72 hpi.
3.2. STX3 is a direct target of hcmv-miR-US33-5p
Using hybrid-PCR and BLAST (http://blast.ncbi.nlm.nih.gov/
Blast.cgi) analysis, 12 putative target mRNAs were identiﬁed from
58 random sequenced clones. Detailed information of the identi-
ﬁed putative target mRNAs of hcmv-miR-US33-5p are shown in
Table 1. Among them, two are HCMV mRNAs and the others are
human mRNAs. A sequence in the 30-UTR of STX3 mRNA from
nucleotides (nt) 1073–1094, in which the ﬁrst nucleotide after
the stop codon of STX3 mRNA is deﬁned as nt 1, was identiﬁed
as a putative binding site of hcmv-miR-US33-5p. The identiﬁed
binding site of hcmv-miR-US33-5p to the 30-UTR of STX3 mRNA
was also predicted by RNAhybrid (http://bibiserv.techfak.uni-bie-
lefeld.de/rnahybrid/submission.html) (Fig. 2A). Binding ability of
hcmv-miR-US33-5p to the 30-UTR sequence of STX3 mRNA was
validated by luciferase reporter assays. As shown in Fig. 2B, the
renilla normalized luciferase activity of pMIR-STX3-UTR was sig-
niﬁcant lower (35%) in cells co-transfected with hcmv-miR-US33-
5p than that in cells co-transfected with miRNA negative control.
The decrease effect of hcmv-miR-US33-5p on luciferase activity
found in pMIR-STX3-UTR was disappeared in pMIR-STX3-MUT,
which contained the sequence with triple point mutations at the
putative binding site. These results demonstrate that hcmv-miR-
US33-5p can directly bind to the predicted binding site in the 30-
UTR of STX3 mRNA.
3.3. Expression of STX3 is down-regulated by over-expressed hcmv-
miR-US33-5p
The regulatory effect of hcmv-miR-US33-5p on STX3 protein
expression was examined by Western blot. As shown in Fig. 3A,
over-expression of hcmv-miR-US33-5p markedly reduced the
endogenous STX3 protein in HCMV infected MRC-5 cells.
Moreover, the reduction was abolished in cells transfected with
inhibitor of hcmv-miR-US33-5p, which can efﬁciently inhibit the
expression of hcmv-miR-US33-5p in infected cells (Fig. 3B). The
results indicate that over-expressed hcmv-miR-US33-5p can
speciﬁcally inhibit the expression of STX3 protein.Accession No. Position of binding
site
NM_017602 30 UTR
NM_001440.2 30 UTR
NM_003128.2 30 UTR
BC007405.2 30 UTR
NM_016282.3 30 UTR
NM_006026.3 30 UTR
NM_003255.4 30 UTR
BC003582.1 30 UTR
BC053521.1 30 UTR
NM_006431.2 CDS
RNAs GU585457.1 30 UTR
UL145 protein (UL145) mRNA, GU585488.1 30 UTR
Fig. 2. hcmv-miR-US33-5p inhibits STX3 expression by targeting STX3 30-UTR. (A) A schematic diagram of predicted binding site of hcmv-miR-US33-5p in the STX3 30-UTR
and mutant nucleotides (underlined) of STX3 30-UTR. The predicted binding site of hcmv-miR-US33-5p is located at nucleotides (nt) 1073–1094 of STX3 30-UTR, in which the
ﬁrst nucleotide after the stop codon of STX3 mRNA is deﬁned as nt 1. (B) Dual luciferase assays in HEK 293 cells cotransfected respectively with pMIR-REPORT vector (pMIR),
vectors containing the wild type of STX3 30-UTR (pMIR-STX3-UTR) and mutant type of STX3 30-UTR (pMIR-STX3-MUT) together with pRL-TK-Renilla-luciferase plasmid, and
respectively with miRNA negative control and hcmv-miR-US33-5p mimics. The transfection efﬁciencies were normalized by the renilla luciferase activities in corresponding
wells. The assays were performed in triplicate wells, ⁄P < 0.01.
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US33-5p through down-regulation of STX3 expression
To investigate whether inhibition of STX3 by hcmv-miR-US33-
5p has effects on HCMV DNA synthesis, small interference RNA
for STX3 was used. With the lower expressions of STX3 (Fig. 4B),
the relative copies of HCMV UL83 gene to that of b-actin in the
MRC-5 cells transfected with hcmv-miR-US33-5p mimics or STX3
siRNA at 48 hpi were markedly lower than those in cells transfec-
ted with miRNA negative control or inhibitor of hcmv-miR-US33-
5p (Fig. 4A). The results indicate that over-expressed hcmv-miR-
US33-5p can inhibit HCMV DNA synthesis through down-regulat-
ing STX3 expression.
3.5. Over-expressed hcmv-miR-US33-5p reduces HCMV replication
ability in MRC-5 cells
In order to exam the inﬂuence of hcmv-miR-US33-5p on viral
replication, the growth kinetics of HCMV Han BAC virus was
detected in MRC-5 cells transfected respectively with miRNA nega-
tive control, hcmv-miR-US33-5p mimics, inhibitor of hcmv-miR-
US33-5p and siRNA of STX3. The titers of the HCMV BAC virus were
similar in different treated cells at 24 hpi. However, at 48 hpi, the
titers of the BAC virus in cells transfected with hcmv-miR-US33-5p
and siRNA of STX3were slightly lower than those in cells transfected
with miRNA negative control and inhibitor of hcmv-miR-US33-5p.
The differences of BAC virus titers between the cells treated with
hcmv-miR-US33-5p or siRNA of STX3 and miRNA negative control
were more obvious at 72 hpi (Fig. 5). These results demonstrate that
ability of HCMV replication can be reduced by over-expressed hcmv-
miR-US33-5p through inhibition of STX3 expression.
4. Discussion
Since the discovery of HCMV miRNAs [13–16], biological func-
tions of some miRNAs have been studied. It was found thathcmv-miR-UL112-1 can suppress expression of major histocom-
patibility complex class I-related chain B (MICB), leading to protec-
tion of HCMV infected cells from natural killer cell recognition [17],
and down regulate HCMV activated interleukin-32 (IL-32) expres-
sion, which may beneﬁt viral immune evasion [18]. Meanwhile,
hcmv-miR-UL112-1 can also target four HCMV genes of IE72
(UL123, IE1), UL112/113, UL120/121 and UL144, which involved
in viral replication [7,19]. hcmv-miR-US25-1 has the abilities to
down regulate expressions of multiple cellular genes associated
with cell cycle control, such as cyclin E2, BRCC3, EID1, MAPRE2
and CD147, by interacting within the 50-UTR of the targets [20],
and reduce the viral replication and DNA synthesis not only of
HCMV but also of other viruses [19]. In addition, over-expression
of miRUS25-2-3p and consequent lower expression of eukaryotic
translation initiation factor 4A1 (eIF4A1) may contribute to the
inhibition of HCMV replication [21]. However, over-expression of
hcmv-miR-UL36 results in a 46.2% decrease in HCMV UL138 pro-
tein expression and a more than threefold increase in HCMV
DNA synthesis at 24 hpi [22]. These results indicate that HCMV uti-
lizes miRNAs to regulate their own genes as well as the host cell
genes during infection to achieve immune evasion, regulation of
cellular processes and viral DNA replication.
As one of the 26 HCMV miRNAs, hcmv-miR-US33 is encoded
by sequence complementary to US29 gene [19]. It has been
reported that hcmv-miR-US33 can inhibit lytic HCMV replication
[8]. It was found that cells expressing hcmv-miR-US33 can atten-
uate luciferase activity in a US29 recombinant luciferase vector
and affect the US29 transcripts at 24 hours post HCMV infection
but not at 48 hpi or 72 hpi [8]. The authors pointed out that
HCMV encoded US29 is a target of hcmv-miR-US33. Moreover,
whether the negative effect of hcmv-miR-US33 on HCMV replica-
tion is mediated by US29 or other host genes remains elusive.
However, the US29 was not selected as a putative target by
hybrid-PCR in our study. It should point out that among the large
number of clones obtained from hybrid-PCR only 58 clones were
selected and sequenced randomly in the study, which may result
Fig. 3. Western blot analyses of STX3 protein expression in MRC-5 cells. (A) Expressions of STX3 in MRC-5 cells transfected respectively with miRNA negative control, hcmv-
miR-US33-5p and inhibitor for hcmv-miR-US33-5p were detected at 48 hours post HCMV Han strain infection by Western blot (Left ﬁgure). The relative expressions of STX3
were normalized to those of GAPDH detected in the corresponding samples. The relative expression of STX3 in the cells transfected with miRNA negative control and infected
with Han strain was deﬁned as 100 arbitrary (arb.) units in each repeated test, ⁄P < 0.01 (Right ﬁgure). (B) Expressions of hcmv-miR-US33-5p in the transfected and infected
MRC-5 cells were detected by quantitative real-time PCR. The numbers of hcmv-miR-US33-5p were normalized to those of snRNA U6 in the corresponding samples by 2DDCT
method. The assays were performed in triplicate wells, ⁄P < 0.01.
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the US29.
In our study, a host gene, STX3, was demonstrated to be a direct
target of hcmv-miR-US33-5p. STX3 is a component of soluble N-
ethylmaleimide-sensitive factor attachment receptors (SNAREs).
Some components of SNAREs are transcriptionally regulated by
HCMV [23]. SNARE proteins drive many membrane fusion events
within eukaryotic cells by the formation of a trans conﬁguration
complex [10]. It has been reported that STX3 can mediate zymo-
gens granule–granule fusion, which might be involved in com-
pound exocytose [24]. Since STX3 is located at the plasma
membrane in epithelial cells [25,26] as well as at plasma mem-
brane and the virus assembly site in HCMV-infected cells [27], it
seems that STX3 participates in membrane fusion events to
envelop HCMV. More importantly, it has been reported that STX3
can incorporate into the HCMV viral envelope and STX3-depletion
can alter particle formation [27]. Meanwhile, it was conﬁrmed that
STX3 is positively associated with HCMV production [27].
In our study, hcmv-miR-US33-5p was identiﬁed to down regu-
late STX3 expression in HCMV infected cells. With repression ofSTX3 protein expression by over-expressed hcmv-miR-US33-5p,
HCMV DNA copies were signiﬁcantly decreased. Silencing hcmv-
miR-US33-5p by its inhibitor resulted in recoveries of HCMV
DNA copy numbers and STX3 protein expression. Similarly, inhibi-
tion of STX3 expression by its speciﬁc siRNA achieved the same
effect on HCMV DNA synthesis as that caused by hcmv-miR-
US33-5p over-expression. Furthermore, similar tendency of HCMV
replication was observed by over-expression of hcmv-miR-US33-
5p. Infectious particles were found begin to produce at 48 hpi,
and were obviously reduced by overexpression of hcmv-miR-
US33-5p and siRNA of STX3 at 72 hpi (Fig. 5). Based on the func-
tions of STX3 in HCMV particle formation and the ﬁndings in our
study, it can be assumed that inhibition of HCMV DNA synthesis
by high level of hcmv-miR-US33-5p is probably mediated by lower
new mature HCMV particles due to lower expression of STX3 in
infected cells. Anyway, results of this study just indicate one possi-
ble way of hcmv-miR-US33-5p on inhibition of HCMV replication.
Other mechanisms on this aspect cannot be excluded.
For all that, viral replication is regulated by many factors, such
as interleukin-10 (IL-10) [28], cellular chromatin-organizing factor
Fig. 4. Effects of hcmv-miR-US33-5p on HCMV DNA copy numbers. (A) HCMV UL83 DNA copies were detected by qPCR in MRC-5 cells transfected respectively with miRNA
negative control, hcmv-miR-US33-5p, inhibitor for hcmv-miR-US33-5p and siRNA for STX3, and infected with HCMV Han strain at 48 hpi. The numbers of HCMV UL83 DNA
copies were normalized to those of b-actin in the corresponding samples by 2DDCT method. The assays were performed in triplicate wells, ⁄P < 0.01. (B) Expressions of STX3
in the transfected and infected MRC-5 cells were detected by Western blot (Left ﬁgure). The relative expressions of STX3 were normalized to those of GAPDH in the
corresponding samples, and that in the cells transfected with miRNA negative control and infected with Han strain was deﬁned as 100 arbitrary (arb.) units in each repeated
test (Right ﬁgure), ⁄P < 0.01.
Fig. 5. Effects of hcmv-miR-US33-5p on HCMV replication. MRC-5 cells transfected
respectively with miRNA negative control, hcmv-miR-US33-5p mimics, inhibitor of
hcmv-miR-US33-5p and siRNA of STX3 were infected with HCMV Han BAC virus. At
24 hpi, 48 hpi and 72 hpi, the cells were collected, frozen and thawed three times.
Infectious particles in the recovered supernatants were titrated by 50% tissue
culture infective dose assay. Results show that ability of HCMV replication can be
reduced by over-expressed hcmv-miR-US33-5p through inhibition of STX3
expression.
X. Guo et al. / FEBS Letters 589 (2015) 440–446 445(CTCF) [29] and host miRNA hsa-miR-200 [30]. Although hcmv-
miR-US33-5p was shown to inhibit STX3 expression, HCMV DNA
synthesis and virus replication by over expression prior to infec-
tion, the effects of relatively low level of naturally expressedhcmv-miR-US33-5p on HCMV replication remind unknown. In
conclusion, our study identiﬁed that hcmv-miR-US33-5p can inhi-
bit HCMV DNA synthesis and virus replication by directly targeting
STX3. Further study waits to understand the biological relevance of
hcmv-miR-US33-5p to the course of HCMV infection, such as
whether it facilitates establishment or maintenance of HCMV
latency.
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